Dr RR Baliga's "Got Knowledge Doc" Podkast

🧠💉 Can vaccines protect the mind? New research suggests that AS01-adjuvanted vaccines like Shingrix and Arexvy may reduce the risk of dementia—possibly by stimulating immune pathways like IFN-γ and TLR4, not just by preventing infection.   📊 In a large US-based EHR study, those who received the RSV or shingles vaccine had a significantly lower 18-month dementia risk than flu-vaccinated peers.  ...

New Insights from the DanGer Shock Trial! 🫀💡   Can early left ventricular unloading with a microaxial flow pump (mAFP) save lives in STEMI-related cardiogenic shock? This compelling substudy shows that mAFP not only boosts cardiac output and power, but also reduces pulmonary pressures—all while using less pharmacologic support. 📉💊   🧪 Native CO improved steadily over 48 hours, hinting at myoc...

🚨 New Breakthrough in Type 2 Diabetes Care! 💊🧬 The ACHIEVE-1 trial shows that Orforglipron , a once-daily oral, nonpeptide GLP-1 receptor agonist , delivers significant reductions in HbA1c and body weight —without injections and with minimal restrictions! 🌍📉   👨‍⚕️ 559 patients across 5 countries ⏱️ 40 weeks, 3 dosing arms (3, 12, 36 mg) 📊 HbA1c ↓ by up to 1.48%, weight ↓ up to 7.6% ✅ No s...

🚨 Frailty matters — even in the cath lab! 🧓🫀   A new NCDR registry analysis of 1.3M+ older adults shows a clear gradient: as frailty increases, so do complications, mortality, and procedural risks during PCI. Severely frail patients faced a striking 20.3% in-hospital mortality and >50% mortality with cardiogenic shock.   🧠 It's time to treat frailty as a vital sign — embedded in our workflow,...

🚨 Major breakthrough in obesity pharmacotherapy! The REDEFINE-1 & REDEFINE-2 trials show that once-weekly CagriSema (Cagrilintide + Semaglutide) delivers up to 20% weight loss in people with obesity—and significant glycemic improvements in those with type 2 diabetes. 💉📉 🌍 Global, double-blind RCTs ⚖️ >90% lost ≥5% body weight 🩺 SBP ↓, QoL ↑, prediabetes reversed in 88% ⚠️ GI side effects comm...

🔥 New Study Alert! 🩺 Wildfire smoke isn't just a respiratory threat — it's taking a toll on the heart, especially in older adults.   📊 A nationwide Medicare cohort (~22M) shows that long-term exposure to wildfire-specific PM2.5 is linked to significantly higher heart failure risk — more so than urban pollution.   📍 Vulnerable groups — women, Medicaid-eligible individuals, and low-income commun...

🧠💊 Appetite Meets Its Match: The Amylin Advantage"   In this episode of Got Knowledge Doc , we explore how amylin , the lesser-known hormone co-secreted with insulin, is making a comeback — this time as part of a dual receptor strategy with GLP-1.   💡 Learn how amylin:   🧠 Activates brainstem satiety centers ⏳ Delays gastric emptying 📉 Suppresses glucagon 🔁 Synergizes with GLP-1 & leptin  ...

🧠💉 When should you start anticoagulation after an ischaemic stroke in atrial fibrillation? The CATALYST meta-analysis may have the answer!   📊 5,441 patients from 4 RCTs ⏱️ Early DOAC (≤4 days) reduced recurrent stroke risk at 30 days ⚖️ No increased bleeding, even in moderate stroke severity 🚫 But patients with PH2 or very severe strokes were excluded Individual Participant Data Meta-Analysis...

🚨 Breakthrough in Type 1 Diabetes! 🧬💉   A new study in NEJM shows that zimislecel , a fully differentiated stem cell–derived islet therapy, restored insulin production and led to insulin independence in 83% of participants! ✅ 📉 HbA1c dropped, 📈 time-in-range soared to 93%, and ⚖️ glucose variability was dramatically reduced.   This marks a major step toward curing—not just managing—Type 1 di...

🧘‍♂️ How Well Can You Sit and Rise from the Floor? 🪑⬆️ That simple motion might say more about your longevity than you think.   A 12-year study of 4,282 adults found that lower Sit–Rise Test (SRT) scores predicted 3.8x higher natural death and 6x higher cardiovascular death rates. 😱   ✅ No equipment ✅ Under 2 minutes ✅ Predicts survival Why aren't we using this more in routine clinical exams...

Aristotle (384–322 BC), a Greek philosopher and polymath, founded the Peripatetic school and Lyceum in Athens.   His extensive works spanned diverse fields, including logic, ethics, politics, biology, and metaphysics, profoundly influencing Western thought, science, and philosophy.

⚡Gatekeepers of Strength: Allopurinol, Calcium & the RyR Revolution"!   Did you know that an old gout drug might hold the key to reversing age-related muscle weakness and heart failure? Using cryo-EM, researchers found that allopurinol and xanthine derivatives directly activate ryanodine receptors—calcium channels essential for muscle contraction.   💡 This could change how we think about cardiac...

🧠🔥 Neuroinflammation: The Common Flame in MS, Stroke, Alzheimer's & Parkinson's   Why do microglia flip from guardians to arsonists? How does immune cell infiltration differ between MS and AD? And which CNS-penetrant therapies show the most promise in dousing the inflammatory fire?   In our latest Got Knowledge Doc podcast, we decode the science behind neuroinflammation, explore treatment fronti...

🔬💓 New Insights on HFimpEF 💓🔬 Heart Failure with Improved Ejection Fraction (HFimpEF) is no longer just a transition phase—it's a distinct, dynamic phenotype with its own risks and management needs.   From biomarkers and imaging to the latest trials like PROSPER-HF and FINEARTS-HF, we're entering an era of more personalized care for these patients.   📈 Better EF ≠ Complete Recovery. 💊 Contin...

🧠 Is your brain orchestrating how fast you age? New insights suggest that aging isn't just about wear and tear—it may be centrally coordinated by the brain through molecules like GDF15, responding to stress, senescence, and energy demands.   💬 Fascinating findings from Nature (June 2025) show how psychological stress accelerates aging at a cellular level—and how lifestyle interventions like exer...

"Obesity Rx 💊❤️🔥: Hormones, Hearts, and Hope" The 2025 ACC guidance reframes obesity as a chronic disease—with precision therapies like GLP-1/GIP agonists now essential in cardiology.   We explore NuSH therapies (semaglutide, tirzepatide), the latest trial data, clinical thresholds for risk reduction, and practical steps for de-stigmatizing care.   👉 Tune in if you're ready to treat obesity lik...

🔬 New meta-analysis alert! 🧪 Researchers compared rapamycin and metformin to dietary restriction across 167 studies in 8 vertebrate species.   📈 Key finding: Rapamycin mirrors dietary restriction's longevity benefits —but metformin falls short.   ⚠️ High heterogeneity and species bias remind us: translation to human health still needs careful navigation.   🧠 Full of insights for aging science,...

🫀 The Heart Ages—But Can We Intervene?   New insights from Nature Reviews Cardiology highlight how endothelial dysfunction, inflammageing, CHIP, and senescence-associated secretory phenotypes (SASP) drive cardiovascular ageing. Promising interventions—from gerotherapeutic diets and exercise to NAD+ boosters, senolytics, and ACBP neutralization—may help delay decline and promote resilience.   💡 C...

  We unpack the UN Scientific Advisory Board Brief on Aging —from telomeres and epigenetic clocks 🧫 to senolytics 💊 and AI-driven geroscience 🤖.   Why does aging matter to every clinician? Because aging is the common soil of all chronic disease. 🌱   🔗 Listen now and join the longevity conversation! #Aging #UNBrief #Geroscience #Epigenetics #Healthspan #GotKnowledgeDoc    

🚨 Game-changing breakthroughs in chimaera research! 🧬💓   From beating human hearts grown in pig embryos to human organoids integrating into mouse intestines and brains via amniotic injection—two bold advances are reshaping the future of organ transplantation and regenerative medicine.   But with scientific promise comes ethical complexity. How far should we go in creating human–animal hybrids?...

🌞 New Guidelines on Vitamin D Supplementation! 💊🧪 JAMA's latest synopsis recommends empirical vitamin D dosing — without routine testing —for children, the elderly, pregnant women, and those with prediabetes. The evidence? Conditional, with wide confidence intervals—but the low cost and minimal harm may tip the scales.   Let's discuss: Is this the dawn of "test less, dose more" in preventive me...

🚨 One in five people carry a hidden cardiovascular risk—do you?   The Brussels Declaration on Lipoprotein(a) calls for global, once-in-a-lifetime Lp(a) testing to prevent premature heart disease and stroke. With strong scientific backing and health equity at its core, this is a pivotal step toward personalized cardiovascular prevention.   🧬 Let's test early. Act early. Save lives. #LipoproteinA...

From baby blood to breakthrough cures — we explore how unlocking fetal hemoglobin through gene editing (exa-cel/Casgevy) is transforming treatment for sickle cell disease and β-thalassemia. 🧬✂️   Featuring the science of BCL11A, CRISPR therapies, and what the future holds for global access 🌍💉   🎧 Tune in: "Switching Gears: From Fetal Hemoglobin to Gene Therapy" #GeneTherapy #CRISPR #HbF #BCL11...

Treat it Early. Treat it Right. Treat it Once. New Lancet comment calls for a paradigm shift in heart valve disease care—advocating early referral , multidisciplinary heart networks , and lifetime management strategies that prioritize durability over delay. Surgery isn't the villain— delay is.   #Cardiology #HeartValveDisease #PrecisionMedicine #SurgicalInnovation #Lancet2025 #LifetimeCare #Multid...

Vasubandhu was a 4th–5th century Indian Buddhist monk, philosopher, and co-founder of the Yogācāra school of Mahayana Buddhism. Renowned for his works on Abhidharma, he developed key philosophical concepts such as "consciousness-only" (vijñaptimātra) and authored texts on Buddhist metaphysics, logic, and meditation. His influential treatises, including Abhidharmakośa and Thirty Verses , significan...